These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

515 related items for PubMed ID: 19787635

  • 1. Surveillance of prophylactic mastectomy: trends in use from 1995 through 2005.
    McLaughlin CC, Lillquist PP, Edge SB.
    Cancer; 2009 Dec 01; 115(23):5404-12. PubMed ID: 19787635
    [Abstract] [Full Text] [Related]

  • 2. Association between clinical characteristics and risk-reduction interventions in women who underwent BRCA1 and BRCA2 testing: a single-institution study.
    Uyei A, Peterson SK, Erlichman J, Broglio K, Yekell S, Schmeler K, Lu K, Meric-Bernstam F, Amos C, Strong L, Arun B.
    Cancer; 2006 Dec 15; 107(12):2745-51. PubMed ID: 17109443
    [Abstract] [Full Text] [Related]

  • 3. Prophylactic Oophorectomy: Reducing the U.S. Death Rate from Epithelial Ovarian Cancer. A Continuing Debate.
    Piver MS.
    Oncologist; 1996 Dec 15; 1(5):326-330. PubMed ID: 10388011
    [Abstract] [Full Text] [Related]

  • 4. Use of genetic testing and prophylactic mastectomy and oophorectomy in women with breast or ovarian cancer from families with a BRCA1 or BRCA2 mutation.
    Meijers-Heijboer H, Brekelmans CT, Menke-Pluymers M, Seynaeve C, Baalbergen A, Burger C, Crepin E, van den Ouweland AW, van Geel B, Klijn JG.
    J Clin Oncol; 2003 May 01; 21(9):1675-81. PubMed ID: 12721241
    [Abstract] [Full Text] [Related]

  • 5. Pathologic characteristics of breast parenchyma in patients with hereditary breast carcinoma, including BRCA1 and BRCA2 mutation carriers.
    Adem C, Reynolds C, Soderberg CL, Slezak JM, McDonnell SK, Sebo TJ, Schaid DJ, Myers JL, Sellers TA, Hartmann LC, Jenkins RB.
    Cancer; 2003 Jan 01; 97(1):1-11. PubMed ID: 12491499
    [Abstract] [Full Text] [Related]

  • 6. Predictors of contralateral prophylactic mastectomy in women with a BRCA1 or BRCA2 mutation: the Hereditary Breast Cancer Clinical Study Group.
    Metcalfe KA, Lubinski J, Ghadirian P, Lynch H, Kim-Sing C, Friedman E, Foulkes WD, Domchek S, Ainsworth P, Isaacs C, Tung N, Gronwald J, Cummings S, Wagner T, Manoukian S, Møller P, Weitzel J, Sun P, Narod SA, Hereditary Breast Cancer Clinical Study Group.
    J Clin Oncol; 2008 Mar 01; 26(7):1093-7. PubMed ID: 18195327
    [Abstract] [Full Text] [Related]

  • 7. Should the use of contralateral prophylactic mastectomy be increasing as it is?
    Wood WC.
    Breast; 2009 Oct 01; 18 Suppl 3():S93-5. PubMed ID: 19914552
    [Abstract] [Full Text] [Related]

  • 8. Contralateral prophylactic mastectomy. Predictors of significant histologic findings.
    Goldflam K, Hunt KK, Gershenwald JE, Singletary SE, Mirza N, Kuerer HM, Babiera GV, Ames FC, Ross MI, Feig BW, Sahin AA, Arun B, Meric-Bernstam F.
    Cancer; 2004 Nov 01; 101(9):1977-86. PubMed ID: 15389473
    [Abstract] [Full Text] [Related]

  • 9. Increasing use of contralateral prophylactic mastectomy for breast cancer patients: a trend toward more aggressive surgical treatment.
    Tuttle TM, Habermann EB, Grund EH, Morris TJ, Virnig BA.
    J Clin Oncol; 2007 Nov 20; 25(33):5203-9. PubMed ID: 17954711
    [Abstract] [Full Text] [Related]

  • 10. A population-based study of bilateral prophylactic mastectomy efficacy in women at elevated risk for breast cancer in community practices.
    Geiger AM, Yu O, Herrinton LJ, Barlow WE, Harris EL, Rolnick S, Barton MB, Elmore JG, Fletcher SW.
    Arch Intern Med; 2005 Mar 14; 165(5):516-20. PubMed ID: 15767526
    [Abstract] [Full Text] [Related]

  • 11. Efficacy of bilateral prophylactic mastectomy in women with a family history of breast cancer.
    Hartmann LC, Schaid DJ, Woods JE, Crotty TP, Myers JL, Arnold PG, Petty PM, Sellers TA, Johnson JL, McDonnell SK, Frost MH, Jenkins RB.
    N Engl J Med; 1999 Jan 14; 340(2):77-84. PubMed ID: 9887158
    [Abstract] [Full Text] [Related]

  • 12. Efficacy of prophylactic mastectomy in women with unilateral breast cancer: a cancer research network project.
    Herrinton LJ, Barlow WE, Yu O, Geiger AM, Elmore JG, Barton MB, Harris EL, Rolnick S, Pardee R, Husson G, Macedo A, Fletcher SW.
    J Clin Oncol; 2005 Jul 01; 23(19):4275-86. PubMed ID: 15795415
    [Abstract] [Full Text] [Related]

  • 13. The predominant role of surgery in the prevention and new trends in the surgical treatment of women with BRCA1/2 mutations.
    Fatouros M, Baltoyiannis G, Roukos DH.
    Ann Surg Oncol; 2008 Jan 01; 15(1):21-33. PubMed ID: 17940826
    [Abstract] [Full Text] [Related]

  • 14. Surgical management of the patient at high risk for breast cancer.
    Temple WJ.
    Can J Surg; 1985 May 01; 28(3):256-7, 261. PubMed ID: 2986809
    [Abstract] [Full Text] [Related]

  • 15. Bilateral prophylactic mastectomy reduces breast cancer risk in BRCA1 and BRCA2 mutation carriers: the PROSE Study Group.
    Rebbeck TR, Friebel T, Lynch HT, Neuhausen SL, van 't Veer L, Garber JE, Evans GR, Narod SA, Isaacs C, Matloff E, Daly MB, Olopade OI, Weber BL.
    J Clin Oncol; 2004 Mar 15; 22(6):1055-62. PubMed ID: 14981104
    [Abstract] [Full Text] [Related]

  • 16. Contentment with quality of life among breast cancer survivors with and without contralateral prophylactic mastectomy.
    Geiger AM, West CN, Nekhlyudov L, Herrinton LJ, Liu IL, Altschuler A, Rolnick SJ, Harris EL, Greene SM, Elmore JG, Emmons KM, Fletcher SW.
    J Clin Oncol; 2006 Mar 20; 24(9):1350-6. PubMed ID: 16549829
    [Abstract] [Full Text] [Related]

  • 17. Lung carcinoma after radiation therapy in women treated with lumpectomy or mastectomy for primary breast carcinoma.
    Zablotska LB, Neugut AI.
    Cancer; 2003 Mar 15; 97(6):1404-11. PubMed ID: 12627503
    [Abstract] [Full Text] [Related]

  • 18. Increasing rates of contralateral prophylactic mastectomy among patients with ductal carcinoma in situ.
    Tuttle TM, Jarosek S, Habermann EB, Arrington A, Abraham A, Morris TJ, Virnig BA.
    J Clin Oncol; 2009 Mar 20; 27(9):1362-7. PubMed ID: 19224844
    [Abstract] [Full Text] [Related]

  • 19. Diagnostic breast magnetic resonance imaging and contralateral prophylactic mastectomy.
    Sorbero ME, Dick AW, Beckjord EB, Ahrendt G.
    Ann Surg Oncol; 2009 Jun 20; 16(6):1597-605. PubMed ID: 19330381
    [Abstract] [Full Text] [Related]

  • 20. Predictors of contralateral prophylactic mastectomy and the impact on breast reconstruction.
    Pinell-White XA, Kolegraff K, Carlson GW.
    Ann Plast Surg; 2014 Jun 20; 72(6):S153-7. PubMed ID: 24691345
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 26.